The {pharmaceutical sector is rapidly exploring novel treatment methods for metabolic conditions, and the introduction of semaglutide 10mg vials represents a significant change. Clinicians are beginning to evaluate the likely benefits and challenges associated with this stronger strength product, notably in relation to existing standard semaglutide